Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KAPAKairos Pharma, LTD.

NYSE · CIK 0001962011
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts119

Identity from submissions API

NameKairos Pharma, LTD.
CIK0001962011
TickersKAPA
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN462993314
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone818-404-5541
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2355 WESTWOOD BLVD. #139
LOS ANGELES
CA
90064
CA
Mailing address
2355 WESTWOOD BLVD. #139
LOS ANGELES
CA
90064
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

127 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 PRE 14A PRE 14A 0001493152-26-053578 001-42275 261580325 34 1173216
2026-11-13 10-Q 10-Q 0001493152-26-051822 001-42275 261553898 34 4609358 1 1
2026-11-05 8-K 8-K 8.01,9.01 0001493152-26-050094 001-42275 261525149 34 248167 1 1
2026-11-03 8-K 8-K 1.01,8.01,9.01 0001493152-26-049744 001-42275 261515477 34 10063881 1 1
2026-10-06 8-K 8-K 8.01,9.01 0001493152-26-045844 001-42275 261442303 34 220383 1 1
2026-09-14 8-K 8-K 7.01,9.01 0001493152-26-042569 001-42275 261377288 34 4356963 1 1
2026-08-21 8-K 8-K 3.03,5.03,7.01,9.01 0001493152-26-039695 001-42275 261305113 34 264644 1 1
2026-08-12 10-Q 10-Q 0001493152-26-037355 001-42275 261267575 34 4915969 1 1
2026-07-22 8-K 8-K 1.01,8.01,9.01 0001493152-26-034185 001-42275 261191735 34 509225 1 1
2026-07-15 8-K 8-K 8.01,9.01 0001493152-26-033289 001-42275 261176028 34 250498 1 1
2026-06-30 8-K 8-K 5.07 0001493152-26-031328 001-42275 261141633 34 234910 1 1
2026-06-04 8-K 8-K 8.01,9.01 0001493152-26-027200 001-42275 261063245 34 242274 1 1
2026-05-26 DEFA14A DEFA14A 0001493152-26-025287 001-42275 261021203 34 16762
2026-05-22 ARS ARS 0001493152-26-025021 001-42275 261013886 34 2956866
2026-05-22 DEF 14A DEF 14A 0001493152-26-025020 001-42275 261013841 34 2711566 1 1
2026-05-18 8-K 8-K 8.01,9.01 0001493152-26-024082 001-42275 26990886 34 31925740 1 1
2026-05-13 10-Q 10-Q 0001493152-26-022796 001-42275 26974670 34 16758567 1 1
2026-05-11 PRE 14A PRE 14A 0001493152-26-022194 001-42275 26962318 34 2496551 1 1
2026-04-01 424B3 424B3 0001493152-26-014692 333-284569 26829123 33 5002147
2026-04-01 424B3 424B3 0001493152-26-014691 333-286662 26829122 33 5003047
2026-03-31 10-K 10-K 0001493152-26-014159 001-42275 26821834 34 11098857 1 1
2026-03-02 8-K 8-K 1.01,8.01,9.01 0001493152-26-008435 001-42275 26703329 34 289592 1 1
2026-02-26 8-K 8-K 8.01,9.01 0001493152-26-008116 001-42275 26681623 34 230534 1 1
2026-01-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000284 333-292686 26558316 33 1715
2026-01-21 CORRESP filename1.htm 0001493152-26-002996 12344
2026-01-15 UPLOAD filename1.pdf 0000000000-26-000555 333-292686 40033
2026-01-13 S-3 S-3 0001493152-26-001909 333-292686 26527994 33 1097355 1 1
2025-12-30 4 4 0001493152-25-029601 5052
2025-12-23 4 4 0001493152-25-028895 7080
2025-11-26 4 4 0001493152-25-025224 5068
2025-11-26 4 4 0001493152-25-025205 7094
2025-11-26 4 4 0001493152-25-025203 4941
2025-11-26 4 4 0001493152-25-025198 5072
2025-11-26 4 4 0001493152-25-025197 5734
2025-11-14 10-Q 10-Q 0001493152-25-023276 001-42275 251484135 34 16912721 1 1
2025-10-15 8-K 8-K 5.02,9.01 0001493152-25-018145 001-42275 251394941 34 256438 1 1
2025-10-07 8-K 8-K 1.01,8.01,9.01 0001493152-25-017208 001-42275 251378269 34 275204 1 1
2025-09-18 8-K 8-K 8.01,9.01 0001493152-25-013975 001-42275 251321799 34 6177284 1 1
2025-09-11 8-K 8-K 8.01,9.01 0001493152-25-013040 001-42275 251307244 34 233374 1 1
2025-09-03 8-K 8-K 8.01,9.01 0001641172-25-026316 001-42275 251287798 34 235827 1 1
2025-08-19 424B3 424B3 0001641172-25-024858 333-284569 251232899 33 2699771
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003587 005-95030 251222147 34 10531
2025-08-12 10-Q 10-Q 0001641172-25-023167 001-42275 251206296 34 4640368 1 1
2025-07-28 10-K/A 10-K/A 0001641172-25-021134 001-42275 251154559 34 706639 1 1
2025-07-15 8-K 8-K 8.01,9.01 0001641172-25-019645 001-42275 251123296 34 229154 1 1
2025-06-12 8-K 8-K 1.01,5.07,9.01 0001641172-25-014905 001-42275 251043771 34 294504 1 1
2025-06-03 8-K 8-K 8.01,9.01 0001641172-25-013368 001-42275 251017219 34 232506 1 1
2025-05-16 DEFR14A DEFR14A 0001641172-25-011229 001-42275 25958709 34 2416680 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002232 005-95030 25951877 34 10356
2025-05-14 10-Q 10-Q 0001641172-25-010089 001-42275 25942550 34 4269456 1 1
2025-05-06 PRER14A PRER14A 0001641172-25-008787 001-42275 25916248 34 2416901 1 1
2025-05-01 DEF 14A DEF 14A 0001641172-25-007922 001-42275 25897759 34 4064389 1 1
2025-04-30 3 xslF345X02/ownership.xml 0001641172-25-007758 4075
2025-04-29 10-K/A AMENDMENT TO THE FORM 10-K 0001641172-25-006509 001-42275 25881899 34 488087 1 1
2025-04-28 8-K 8-K 4.01,9.01 0001641172-25-006504 001-42275 25881700 34 217860 1 1
2025-04-25 424B3 form424b3.htm 0001641172-25-006278 333-286662 25875195 33 901682
2025-04-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001242 333-286662 25869719 33 1715
2025-04-24 8-K form8-k.htm 8.01,9.01 0001641172-25-005946 001-42275 25863709 34 237692 1 1
2025-04-22 CORRESP filename1.htm 0001641172-25-005650 14178
2025-04-22 S-1 forms-1.htm 0001641172-25-005602 333-286662 25854671 33 1095862
2025-04-15 10-K form10-k.htm 0001641172-25-004920 001-42275 25840720 34 7707396 1 1
2025-04-07 4 xslF345X05/ownership.xml 0001641172-25-002927 5089
2025-03-28 NT 10-K formnt10-k.htm 0001641172-25-001186 001-42275 25786073 34 32538
2025-03-20 8-K form8-k.htm 8.01,9.01 0001493152-25-010977 001-42275 25754500 34 256322 1 1
2025-02-26 8-K form8-k.htm 8.01,9.01 0001493152-25-008268 001-42275 25666125 34 243048 1 1
2025-02-24 4 xslF345X05/ownership.xml 0001493152-25-008106 5140
2025-02-24 4 xslF345X05/ownership.xml 0001493152-25-008105 5089
2025-02-10 DEF 14C formdef14c.htm 0001493152-25-005657 001-42275 25606310 34 111994
2025-02-06 8-K form8-k.htm 8.01,9.01 0001493152-25-005100 001-42275 25595632 34 240727 1 1
2025-02-05 424B3 form424b3.htm 0001493152-25-004882 333-284569 25590720 33 10072823 1 1
2025-02-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000308 333-284569 25590619 33 1722
2025-01-31 CORRESP filename1.htm 0001493152-25-004493 13486
2025-01-31 UPLOAD filename1.pdf 0000000000-25-001047 333-284569 39996
2025-01-29 PRE 14C formpre14c.htm 0001493152-25-004079 001-42275 25566688 34 111665
2025-01-29 S-1 forms-1.htm 0001493152-25-004041 333-284569 25566614 33 10369935 1 1
2025-01-28 D xslFormDX01/primary_doc.xml 06b 0001493152-25-003984 021-536526 25564233 33 12227
2025-01-17 8-K form8-k.htm 1.01,3.02,9.01 0001493152-25-002832 001-42275 25539618 34 990534 1 1
2025-01-14 8-K form8-k.htm 1.01,3.02,9.01 0001493152-25-002048 001-42275 25527959 34 1132512 1 1
2025-01-06 UPLOAD filename1.pdf 0000000000-25-000132 377-07661 40277
2025-01-03 DRS filename1.htm 0001493152-25-000210 377-07661 25505209 33 3162048
2024-12-13 8-K form8-k.htm 5.02,9.01 0001493152-24-049994 001-42275 241548429 34 271521 1 1
2024-11-25 4 xslF345X05/ownership.xml 0001493152-24-047695 4523
2024-11-25 4 xslF345X05/ownership.xml 0001493152-24-047526 4527
2024-11-21 4 xslF345X05/ownership.xml 0001493152-24-047261 4476
2024-11-19 8-K form8-k.htm 7.01,9.01 0001493152-24-046707 001-42275 241473464 34 278231 1 1
2024-11-14 10-Q form10-q.htm 0001493152-24-045671 001-42275 241460326 34 5756385 1 1
2024-10-10 8-K form8-k.htm 8.01,9.01 0001493152-24-040780 001-42275 241365953 34 32892204 1 1
2024-10-04 8-K form8-k.htm 1.01,9.01 0001493152-24-039586 001-42275 241355767 34 270605 1 1
2024-09-27 S-8 forms-8.htm 0001493152-24-038599 333-282391 241335987 33 155146
2024-09-27 8-K form8-k.htm 1.01,9.01 0001493152-24-038590 001-42275 241335924 34 750667 1 1
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038032 3533
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038031 3523
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038030 3575
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038029 3575
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038028 3578
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038027 3526
2024-09-24 3 xslF345X02/ownership.xml 0001493152-24-038026 3539
2024-09-24 8-K form8-k.htm 1.01,8.01,9.01 0001493152-24-037958 001-42275 241320430 34 373091 1 1
2024-09-17 8-K form8-k.htm 1.01,7.01,9.01 0001493152-24-036855 001-42275 241304613 34 911419 1 1
2024-09-17 424B4 form424b4.htm 0001493152-24-036474 333-274805 241302547 33 3200467
2024-09-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-16 10:30:00 9999999995-24-002852 333-274805 241302417 33 1723
2024-09-13 CORRESP filename1.htm 0001493152-24-036216 12301
2024-09-13 CORRESP filename1.htm 0001493152-24-036173 17086
2024-09-13 CORRESP filename1.htm 0001493152-24-036171 12347
2024-09-12 CERT NYSE AMERICAN CERTIFICATION 0001143313-24-000088 001-42275 241294553 34 390663
2024-09-12 8-A12B form8a-12b.htm 0001493152-24-035986 001-42275 241294412 34 24308
2024-09-09 CORRESP filename1.htm 0001493152-24-035460 11581
2024-09-09 CORRESP filename1.htm 0001493152-24-035422 17223
2024-08-16 S-1/A forms-1a.htm 0001493152-24-032896 333-274805 241217722 33 3600165
2024-06-04 S-1/A forms-1a.htm 0001493152-24-022450 333-274805 241015816 33 3316448
2024-06-03 CORRESP filename1.htm 0001493152-24-022452 16633
2024-05-24 S-1/A forms-1a.htm 0001493152-24-021364 333-274805 24984753 33 3314972
2024-05-20 S-1/A forms-1a.htm 0001493152-24-020539 333-274805 24962396 33 3312211
2024-05-13 S-1/A forms-1a.htm 0001493152-24-018727 333-274805 24936605 33 3313022
2024-05-01 S-1/A forms-1a.htm 0001493152-24-017318 333-274805 24899577 33 3732941
2024-02-14 S-1/A forms-1a.htm 0001493152-24-006764 333-274805 24640782 33 3543187
2023-12-07 S-1/A forms-1a.htm 0001493152-23-043914 333-274805 231470655 33 3543492
2023-09-29 S-1 forms-1.htm 0001493152-23-034915 333-274805 231296786 33 9579805
2023-09-18 DRS/A filename1.htm 0001493152-23-032840 377-06654 231259961 33 3486057
2023-09-15 DRSLTR filename1.htm 0001493152-23-032842 33799
2023-07-06 UPLOAD filename1.pdf 0000000000-23-007216 377-06654 53267
2023-06-28 DRSLTR filename1.htm 0001493152-23-022727 87165
2023-06-28 DRS/A filename1.htm 0001493152-23-022725 377-06654 231050474 33 58404988
2023-06-28 DRS/A filename1.htm 0001493152-23-022724 377-06654 231050424 33 67312370
2023-04-27 D xslFormDX01/primary_doc.xml 06b 0001493152-23-013724 021-480119 23851219 33 10980
2023-04-25 UPLOAD filename1.pdf 0000000000-23-004179 377-06654 72584
2023-03-29 DRS filename1.htm 0001493152-23-009350 377-06654 23771465 33 2645932

Latest XBRL company facts

One latest value per concept from companyfacts (119 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.69M 2026-11-13 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
dei EntityPublicFloat Entity Public Float USD 6.90M 2025-06-30 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 495,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AccountsPayableTradeCurrentAndNoncurrent Accounts Payable, Trade USD 15.00M 2026-03-02 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AdditionalCollateralAggregateFairValue Additional Collateral, Aggregate Fair Value USD 500,000 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 23.16M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 5,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 29,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 154,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 62,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 717,563 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap Assets Assets USD 4.37M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AssetsCurrent Assets, Current USD 3.35M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap Cash Cash USD 1.27M 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.13M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 3.13M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.29 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 638,000 2023-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 250,000 2022-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap CustomerAdvancesAndDeposits Customer Advances and Deposits USD 3.12M 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 142,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 3,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 105,000 2023-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 105,000 2023-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 239,000 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 239,000 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 482,000 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.77M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 3.25M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 386,000 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 3.01M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.28 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.039 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 29,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 191,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037355
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001493152-26-022796
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 102,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -13,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -381,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 296,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 62,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 35,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 3,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap InterestReceivable Interest Receivable USD 0 2023-12-31 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap InvestmentIncomeNet Investment Income, Net USD 90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap Liabilities Liabilities USD 992,000 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 4.37M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap LiabilitiesCurrent Liabilities, Current USD 495,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -5.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap OperatingExpenses Operating Expenses USD 5.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -5.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 9.90M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 727,000 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 193,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 670,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 2.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 900,000 2024-10-01 2024-10-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 209,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 25,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.06M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023276
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 3.06M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 3.60M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 142,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 142,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 10,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -19.29M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ServicingAssetAtAmortizedValue Servicing Asset at Amortized Cost USD 18,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037355
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 278,188 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 93,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 80,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045671
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 3.88M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 514,940 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 551,100 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010089
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 884,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 1.79M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 7,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 75.00M 2026-01-01 2026-01-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.88M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014159
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 777,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 218,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0001641172-25-004920
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051822

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →